Abou Dalle, Iman
Jabbour, Elias
Short, Nicholas J.
Ravandi, Farhad
Article History
First Online: 24 January 2019
Compliance with Ethical Standards
:
: Iman Abou Dalle declares that she has no conflict of interest.Elias Jabbour has received research funding from Takeda, Pfizer, and Amgen.Nicholas J. Short has received compensation from Takeda for service as a consultant.Farhad Ravandi has received research funding from Bristol-Myers Squibb, honoraria from Ariad, and has served on an advisory board for Bristol-Myers Squibb.
: This article does not contain any studies with human or animal subjects performed by any of the authors.